FXAIX
Price
$208.82
Change
+$2.15 (+1.04%)
Updated
Jun 6 closing price
Net Assets
633.85B
GSRCX
Price
$11.63
Change
+$0.10 (+0.87%)
Updated
Jun 6 closing price
Net Assets
431.85M
Interact to see
Advertisement

FXAIX vs GSRCX

Header iconFXAIX vs GSRCX Comparison
Open Charts FXAIX vs GSRCXBanner chart's image
Fidelity 500 Index
Price$208.82
Change+$2.15 (+1.04%)
VolumeN/A
Net Assets633.85B
Goldman Sachs Rising Dividend Gr C
Price$11.63
Change+$0.10 (+0.87%)
VolumeN/A
Net Assets431.85M
FXAIX vs GSRCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FXAIX vs. GSRCX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and GSRCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 634B vs. GSRCX (432M). FXAIX pays higher dividends than GSRCX: FXAIX (1.26) vs GSRCX (0.67). FXAIX was incepted earlier than GSRCX: FXAIX (14 years) vs GSRCX (20 years). GSRCX (2.02) is less costly to investors than FXAIX (0.01). GSRCX is a more actively managed with annual turnover of: 42.00 vs. FXAIX (2.00). FXAIX has a lower initial minimum investment than GSRCX: FXAIX (0) vs GSRCX (1000). FXAIX annual gain was more profitable for investors over the last year : 12.43 vs. GSRCX (-6.66). FXAIX return over 5 years is better than : 100.49 vs. GSRCX (19.12).
FXAIXGSRCXFXAIX / GSRCX
Total Expense Ratio0.011.761%
Annual Report Gross Expense Ratio0.012.021%
Fund Existence14 years20 years-
Gain YTD1.5370.234658%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets634B432M146,759%
Annual Yield % from dividends1.260.67187%
Returns for 1 year12.43-6.66-187%
Returns for 3 years49.35-3.93-1,256%
Returns for 5 years100.4919.12526%
Returns for 10 years212.02-40.75-520%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAK1.290.10
+8.40%
Northern Dynasty Minerals Ltd
TSBX0.360.01
+3.05%
Turnstone Biologics Corp
NWSA27.81-0.05
-0.18%
News Corp
TSHA2.84-0.04
-1.39%
Taysha Gene Therapies
MLTX46.88-1.95
-3.99%
MoonLake Immunotherapeutics